PRAC December 2023: recommendation of measures to minimise the risk of serious side effects with medicines containing pseudoephedrine
Annual report on the donation of human body material: increase in the declarations of explicit content and reduction in opposition
Conditions for reuse (Creative Commons-0 licence)
Unless stated otherwise, the information on this website is free of rights and may be used for private, association, scientific and commercial purposes. The FAMHP does, however, recommend stating the source and date of the information that is reused.
Where prior authorisation is required, or where specific conditions are necessary, reuse restrictions are explicitly mentioned. The reuse of multimedia content (photographs, images, sound, videos, etc.), including the content contained in downloadable documents (brochures, etc.), is always subject to prior approval.
Social media
The Federal Agency for Medicines and Health Products uses the following official social media channels:
The FAMHP and European projects
The FAMHP actively participates in a number of programmes and funds financed by the European Union.
1. Ongoing projects
- The UNICOM project
Partners receiving financial support from the FAMHP
BCFI
The Belgian Centre for Pharmacotherapeutic Information asbl/vzw (BCFI/CBIP) is subsidised and logistically supported by the FAMHP and issues the Commented Repertory of Medicines, the Folia Pharmacotherapeutica and the Transparency worksheets. These publications are sent for free to doctors, pharmacists and dentists.